These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3629 related items for PubMed ID: 31054549

  • 21. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J, Rectal Cancer Consortium.
    BMC Cancer; 2015 Oct 23; 15():767. PubMed ID: 26497495
    [Abstract] [Full Text] [Related]

  • 22. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
    Zhu J, Gu W, Lian P, Sheng W, Cai G, Shi D, Cai S, Zhang Z.
    Radiat Oncol; 2013 May 29; 8():130. PubMed ID: 23718210
    [Abstract] [Full Text] [Related]

  • 23. Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial).
    Akiyoshi T, Shinozaki E, Taguchi S, Chino A, Hiratsuka M, Tominaga T, Nonaka T, Toda S, Matoba S, Matsui S, Okabayashi K, Mukai T, Hiyoshi Y, Yamaguchi T, Nagasaki T, Yamaguchi K, Ueno M, Kuroyanagi H, Fukunaga Y, Ishizuka N, Konishi T, for NOMINATE Collaborative Group.
    BMJ Open; 2022 Mar 18; 12(3):e055140. PubMed ID: 35304396
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.
    Gao YH, An X, Sun WJ, Cai J, Cai MY, Kong LH, Lin JZ, Liu GC, Tang JH, Wu XJ, Chen G, Pan ZZ, Ding PR.
    J Surg Oncol; 2014 Apr 18; 109(5):478-82. PubMed ID: 24288203
    [Abstract] [Full Text] [Related]

  • 25. Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.
    Kim MJ, Lee DW, Kang HC, Park JW, Ryoo SB, Han SW, Kim KS, Chie EK, Oh JH, Jeong WK, Kim BH, Nam EM, Jeong SY.
    BMC Cancer; 2023 Aug 08; 23(1):734. PubMed ID: 37553666
    [Abstract] [Full Text] [Related]

  • 26. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW, Zang L, Ma JJ, Sun J, Yang X, Wang ML, Lu AG, Hu WG, Zheng MH.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):138-144. PubMed ID: 33508919
    [Abstract] [Full Text] [Related]

  • 27. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
    Wang Y, Shen L, Wan J, Zhang H, Wu R, Wang J, Wang Y, Xu Y, Cai S, Zhang Z, Xia F.
    BMC Cancer; 2022 Mar 15; 22(1):274. PubMed ID: 35291966
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
    Konishi T, Shinozaki E, Murofushi K, Taguchi S, Fukunaga Y, Nagayama S, Fujimoto Y, Akiyoshi T, Nagasaki T, Suenaga M, Chino A, Kawachi H, Yamamoto N, Ishikawa Y, Oguchi M, Ishizuka N, Ueno M, Yamaguchi K.
    Ann Surg Oncol; 2019 Aug 15; 26(8):2507-2513. PubMed ID: 30963400
    [Abstract] [Full Text] [Related]

  • 30. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
    Sun Y, Wu X, Zhang Y, Lin H, Lu X, Huang Y, Chi P.
    Eur J Surg Oncol; 2019 Jul 15; 45(7):1225-1231. PubMed ID: 30879932
    [Abstract] [Full Text] [Related]

  • 31. Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
    Voogt ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Willems J, Cnossen JS, Peulen HMU, Nederend J, van Lijnschoten G, Burger JWA, Rutten HJT.
    Eur J Surg Oncol; 2021 Sep 15; 47(9):2429-2435. PubMed ID: 34030921
    [Abstract] [Full Text] [Related]

  • 32. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials.
    Fokas E, Williams H, Diefenhardt M, Lin S, Qin LX, Piso P, Dapper H, Germer CT, Grützmann R, Tim Friede J, Joshua Smith J, Saltz LB, Wu AJ, Weiser MR, Omer D, Ghadimi M, Hofheinz RD, Garcia-Aguilar J, Rödel C, German Rectal Cancer Study Group and the OPRA Consortium.
    Eur J Cancer; 2024 Oct 15; 210():114291. PubMed ID: 39180940
    [Abstract] [Full Text] [Related]

  • 33. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.
    Sclafani F, Brown G, Cunningham D, Rao S, Tekkis P, Tait D, Morano F, Baratelli C, Kalaitzaki E, Rasheed S, Watkins D, Starling N, Wotherspoon A, Chau I.
    Oncologist; 2017 Jun 15; 22(6):728-736. PubMed ID: 28476941
    [Abstract] [Full Text] [Related]

  • 34. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A, Wang L, Du C, Peng Y, Yao Y, Zhao J, Zhan T, Cai Y, Li Y, Sun Y, Ji J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr 25; 20(4):417-424. PubMed ID: 28440523
    [Abstract] [Full Text] [Related]

  • 35. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW, Kang BM, Kim IY, Kim JY, Park SJ, Park WC, Bae KB, Bae BN, Baek SK, Baik SH, Son GM, Lee YS, Lee SH.
    BMC Cancer; 2018 May 08; 18(1):538. PubMed ID: 29739356
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z, Fang S, Ding Z, Mao D, Pang P, Gong X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep 25; 21(9):1051-1058. PubMed ID: 30269327
    [Abstract] [Full Text] [Related]

  • 38. Neoadjuvant-intensified treatment for rectal cancer: time to change?
    Musio D, De Felice F, Bulzonetti N, Guarnaccia R, Caiazzo R, Bangrazi C, Raffetto N, Tombolini V.
    World J Gastroenterol; 2013 May 28; 19(20):3052-61. PubMed ID: 23716984
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials.
    Moretto R, Vetere G, Carullo M, Ciracì P, Masi G, Cremolini C.
    Cancer Treat Rev; 2024 Nov 28; 130():102829. PubMed ID: 39305700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 182.